NPPA and obesity due to melanocortin 4 receptor deficiency: Although ANP levels are lower, ANP may provide some of its cardiovascular protective effects in individuals with obesity and diabetes to reduce vascular stiffness and inflammation by regulating pro-inflammatory cytokines [20].